Gwen Stemple, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7511 Mayfield Rd, Chesterland, OH 44026 Phone: 440-257-8791 |
Gregory James Murmann, MSN, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 11153 Winding Brook Ln, Chesterland, OH 44026 Phone: 216-294-8292 |
Mrs. Terri H Morris, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 8947 Cedar Rd, Chesterland, OH 44026 Phone: 440-729-7595 |
Mrs. Cheryl Lynn Sharaba, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8125 Mulberry Rd, Chesterland, OH 44026 Phone: 440-729-1979 |
Mrs. Peggy Anne Congin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9989 Mayfield Rd, Chesterland, OH 44026 Phone: 440-286-7636 Fax: 440-286-4654 |
Mrs. Wendy Lou Rosenbaum, Registered Nurse - Emergency Medicare: Not Enrolled in Medicare Practice Location: 8391 Whiting Dr, Chesterland, OH 44026 Phone: 440-729-6518 |
News Archive
Albert Einstein College of Medicine of Yeshiva University researcher Jeffrey Pollard, Ph.D., has received the prestigious Medal of Honor in Basic Science from the American Cancer Society (ACS) in recognition of his research into the critical role the tumor microenvironment plays in modulating cancer behavior, specifically the role that members of the innate immune cells called macrophages play both in normal development and in promoting tumor progression. These macrophages could hold the key to more targeted cancer treatments.
The New York Times profiles Rep. Paul Ryan, R-Wis., and details the rising Republican star's positions on health care and social programs, among other things. Under his controversial "Roadmap for America's Future" plan, Ryan would eliminate the federal debt over 50 years through major changes to Medicare and Social Security.
Shire plc, the global specialty biopharmaceutical company, today presented positive top line results of the first European phase III study of once-daily lisdexamfetamine dimesylate (LDX) in children and adolescents aged 6 to 17 years with Attention-Deficit/Hyperactivity Disorder.
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.
› Verified 6 days ago